Stock Fundamentals

Company Information

Company Name
Regeneron Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75886F1075
CIK: 0000872589
CUSIP: 75886F107
Currency: USD
Full Time Employees: 15,343
Phone: 914 847 7000
Fiscal Year End: December
IPO Date: Apr 02, 1991
Description:

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma; Libtayo injection for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection to treat heterozygous familial hypercholesterolemia (HoFH); and Kevzara solution for rheumatoid arthritis. It has license and collaboration agreement with Bayer for the development and commercialization of EYLEA 8 mg and EYLEA; Alnylam Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for diseases by addressing therapeutic disease targets expressed in the eye and central nervous system; Intellia Therapeutics, Inc. to advance CRISPR/Cas9 gene-editing technology for in vivo therapeutic development for therapies focused on neurological and muscular diseases; Hansoh Pharmaceuticals Group Company Limited to acquire development and commercial rights for HS-20094, a dual GLP-1/GIP receptor; and Tessera Therapeutics, Inc. develops and commercializes TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. Additionally, the company has a strategic collaboration with Telix Pharmaceuticals Limited to develop and commercialize radiopharmaceutical therapies. The company was incorporated in 1988 and is based in Tarrytown, New York.

Address:

777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707

Directors & Officers

Name Title Year Born
Dr. Leonard S. Schleifer M.D., Ph.D. Co-Founder, President, CEO & Co-Chairman 1953
Dr. George D. Yancopoulos M.D., Ph.D. Co-Founder, President, Chief Scientific Officer & Co-Chairman 1960
Mr. Christopher R. Fenimore CPA Executive VP of Finance & CFO 1971
Mr. Joseph J. LaRosa J.D. Executive VP, General Counsel & Secretary 1959
Dr. Andrew J. Murphy Ph.D. Executive VP of Research & Co-Chief Scientific Officer 1958
Mr. Daniel P. Van Plew Executive VP and GM of Industrial Operations & Product Supply 1973
Mr. Rajesh Ahuja Senior Vice President of Quality Assurance & Operations NA
Mr. Ryan Steinberger Executive VP, Chief Digital & Technology Officer NA
Mr. Ryan Crowe Senior Vice President of Investor Relations & Strategic Analysis NA
Ms. Melissa Lozner Senior VP & Chief Compliance Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 19, 2026 Huda Y Zoghbi N/A Sale 1.64K $781.33 $1.28M
Feb 12, 2026 Julia Letlow N/A Purchase N/A $783.65 N/A
Feb 09, 2026 Arthur F Ryan N/A Sale 100.00 $778.53 $77.85K
Feb 09, 2026 Jason Pitofsky N/A Sale 2.04K $778.52 $1.59M
Jan 29, 2026 Ro Khanna N/A Sale N/A $749.44 N/A
Jan 23, 2026 Ro Khanna N/A Purchase N/A $753.55 N/A
Jan 07, 2026 Bonnie L Bassler N/A Sale 1.50K $800.00 $1.20M
Nov 18, 2025 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $725.34 N/A
Nov 07, 2025 Jason Pitofsky N/A Sale 431.00 $651.43 $280.77K
Nov 03, 2025 Ro Khanna N/A Purchase N/A $642.25 N/A
Oct 29, 2025 Christine A Poon N/A Sale 6.50K $654.27 $4.25M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 9.08M Dec 31, 2025 8.66% $0.10 0.30%
BlackRock Inc 8.95M Mar 31, 2026 8.53% $0.12 2.36%
Vanguard Capital Management, LLC 6.65M Mar 31, 2026 6.35% $0.13 0.00%
State Street Corp 4.66M Mar 31, 2026 4.45% $0.12 0.08%
Dodge & Cox 4.46M Mar 31, 2026 4.25% $1.89 -3.01%
JPMorgan Chase & Co 4.31M Mar 31, 2026 4.11% $0.21 9.43%
Franklin Resources Inc 2.72M Mar 31, 2026 2.60% $0.52 6.33%
Geode Capital Management, LLC 2.61M Mar 31, 2026 2.49% $0.12 3.50%
T. Rowe Price Associates, Inc. 2.18M Mar 31, 2026 2.08% $0.19 11.68%
Nuveen, LLC 2.07M Mar 31, 2026 1.97% $0.43 2.71%
Loomis, Sayles & Company LP 1.91M Mar 31, 2026 1.82% $1.99 -1.14%
Wellington Management Company LLP 1.84M Mar 31, 2026 1.75% $0.27 176.53%
Amvescap Plc. 1.72M Mar 31, 2026 1.64% $0.20 8.38%
Vanguard Portfolio Management, LLC 1.72M Mar 31, 2026 1.64% $0.07 0.00%
FMR Inc 1.52M Mar 31, 2026 1.45% $0.06 -34.55%
Capital World Investors 1.42M Mar 31, 2026 1.35% $0.15 1.50%
Morgan Stanley - Brokerage Accounts 1.32M Mar 31, 2026 1.26% $0.06 -5.04%
NORGES BANK 1.31M Dec 31, 2025 1.25% $0.11 9.61%
The Goldman Sachs Group Inc 1.30M Mar 31, 2026 1.24% $0.12 18.52%
AQR Capital Management LLC 1.23M Mar 31, 2026 1.17% $0.43 23.63%

Shares Statistics

Shares Outstanding: 103.02M
Shares Float: 97.67M
% Insiders: 203.30%
% Institutions: 9,224.80%
Short % Float: 3.03%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.31M 3.16% ▲ 0.27% Apr 30, 2026
2 Dodge & Cox Stock I 2.91M 2.77% ▼ 2.87% Mar 31, 2026
3 Vanguard 500 Index Investor 2.61M 2.49% ▲ 1.83% Apr 30, 2026
4 Invesco QQQ Trust 2.25M 2.15% ▲ 0.47% May 29, 2026
5 iShares Core S&P 500 ETF 1.33M 1.27% ▲ 0.31% May 29, 2026
6 Fidelity 500 Index 1.29M 1.23% ▲ 0.35% Apr 30, 2026
7 State Street® SPDR® S&P 500® ETF 1.21M 1.16% ▲ 0.11% May 31, 2026
8 Putnam Large Cap Value A 1.14M 1.09% ▲ 0.00% Apr 30, 2026
9 Vanguard Value Index Inv 963.08K 0.92% ▲ 0.29% Apr 30, 2026
10 Vanguard Wellington Inv 854.40K 0.82% ▲ 56.04% Mar 31, 2026

Valuation Metrics

Enterprise Value: $58.13B
Trailing P/E: 14.95
Forward P/E: 13.64

Financial Highlights

Market Cap: $64.18B
EBITDA: $4.38B
P/E Ratio: $14.95
PEG Ratio: $1.07
Book Value: $308.33
Dividend/Share: $3.58
Dividend Yield: 0.59%
Earnings/Share: $40.95
Profit Margin: 29.65%
Operating Margin: 20.66%
ROA (TTM): 6.13%
ROE (TTM): 14.55%
Revenue (TTM): $14.92B
Revenue/Share (TTM): $143.56
Earnings Growth (YOY): -7.20%
Revenue Growth (YOY): 19.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.13x 0.06x 0.23x 81.69x 0.35x
2024-12-31 4.73x 0.07x 0.22x 72.30x 0.37x
2023-12-31 5.69x 0.08x 0.21x 55.44x 0.49x
2022-12-31 5.06x 0.12x 0.22x 90.67x 0.51x
2021-12-31 3.56x 0.14x 0.26x 156.14x 0.28x
2020-12-31 4.54x 0.33x 0.36x 62.86x 0.88x
2019-12-31 3.67x 0.00x 0.25x 73.17x 0.00x
2018-12-31 5.89x 0.01x 0.25x 89.87x 0.03x
2017-12-31 5.79x 0.19x 0.30x 82.79x 0.53x
2016-12-31 3.15x 0.11x 0.36x 184.95x 0.34x
2015-12-31 4.45x 0.22x 0.35x 87.91x 0.61x
2014-12-31 4.04x 0.20x 0.34x 22.43x 0.56x
2013-12-31 7.54x 0.16x 0.34x 16.37x 0.40x
2012-12-31 9.91x 0.24x 0.40x 10.10x 0.60x
2011-12-31 6.16x 0.57x 0.63x -9.64x -1.59x
2010-12-31 6.60x 0.30x 0.52x -10.69x -2.06x
2009-12-31 4.55x 0.27x 0.46x -31.71x -1.97x
2008-12-31 6.23x 0.39x 0.37x -11.59x -2.07x
2007-12-31 2.81x 0.43x 0.51x -9.50x -2.44x
2006-12-31 10.44x 1.02x 0.63x -6.48x -2.89x
2005-12-31 8.46x 1.96x 0.73x -3.03x -3.29x
2004-12-31 10.08x 1.20x 0.61x 0.12x 3.16x
2003-12-31 4.39x 1.55x 0.71x -22.41x -2.34x
2002-12-31 6.90x 1.37x 0.63x -12.93x -1.76x
2001-12-31 17.90x 0.75x 0.46x -7.05x -2.52x
2000-12-31 9.73x 0.01x 0.13x -5.52x -0.13x
1999-12-31 5.49x 0.01x 0.20x -23.80x -0.07x
1998-12-31 9.88x 0.01x 0.16x -2.84x -0.12x
1997-12-31 9.31x 0.01x 0.18x -2.21x -0.19x
1996-12-31 7.08x 0.03x 0.22x -1.21x -0.32x
1995-12-31 3.81x 0.05x 0.28x -0.52x -2.06x
1994-12-31 2.91x 0.05x 0.29x N/A -0.12x
1993-12-31 7.01x 0.02x 0.16x N/A -0.04x
1992-12-31 18.41x 0.01x 0.11x N/A -0.06x
1991-12-31 32.30x 0.00x 0.07x -1.85x -0.05x
1990-12-31 12.44x 0.00x 0.52x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about REGN.US!